{"title":"Ultra-thin, evaporation-resistent PDMS devices for absolute quantification of DNA using digital PCR","authors":"H. Zec, C. O’Keefe, Polly C. Ma, Tza-Huei Wang","doi":"10.1109/TRANSDUCERS.2015.7180979","DOIUrl":null,"url":null,"abstract":"We present an array-based nanoliter digital PCR (dPCR) platform. The ultra-thin microfluidic device can accommodate high temperatures for extended periods, while minimizing evaporation. The device utilizes a very simple fabrication scheme, and can achieve a limit of detection of 100 attomolar of synthetic target. dPCR presents a feasible way to quantify rare targets, especially in high background. We demonstrate proof-of-concept use of this device to identify methylation of synthetic DNA in high background, a potential biomarker for many diseases. We believe that this simple and cost-effective device will encourage wider adoption of dPCR.","PeriodicalId":6465,"journal":{"name":"2015 Transducers - 2015 18th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2015 Transducers - 2015 18th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/TRANSDUCERS.2015.7180979","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
We present an array-based nanoliter digital PCR (dPCR) platform. The ultra-thin microfluidic device can accommodate high temperatures for extended periods, while minimizing evaporation. The device utilizes a very simple fabrication scheme, and can achieve a limit of detection of 100 attomolar of synthetic target. dPCR presents a feasible way to quantify rare targets, especially in high background. We demonstrate proof-of-concept use of this device to identify methylation of synthetic DNA in high background, a potential biomarker for many diseases. We believe that this simple and cost-effective device will encourage wider adoption of dPCR.